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Formation of an apparent virion precursor, the provirion, can be demonstrated
in cytoplasmic extracts of poliovirus-infected HeLa cells.
We have reported the isolation and character-
ization of a new subviral particle from poli-
ovirus-infected cells (1). This ribonucleoprotein
complex has been termed the provirion, in
recognition of its apparent status as a direct
virion precursor. Provirion has the protein com-
position of the procapsid and RNA of the same
size as poliovirion RNA (35S).
To investigate further the mechanism of pro-
virion synthesis and the possible role of the
particle as an intermediate in virion mor-
phogenesis, a cell-free system has been devel-
oped which allows in vitro formation of provi-
rion. A cytoplasmic extract was prepared from
HeLa cells which had been infected with polio-
virus for 3.5 h and which had been labeled with
3H-leucine for 30 min and with 14C-uridine for
15 min. One half of the cytoplasmic extract was
incubated at 37 C for 30 min, whereas the other
half remained at 0 C. The extracts were then
adjusted to 1% DOC and 1% Brij-58 and the
samples were sedimented through sucrose gra-
dients. The gradients were fractionated and
portions of each fraction were assayed directly
for acid-precipitable radioactivity (Fig. la and
c), while equal portions were assayed after
ribonuclease digestion (Fig. lb and d).
As shown previously (1), the unincubated
sample (Fig. la) contained virions (155S) and a
small peak of provirions (125S) both of which
were evident in the A260 profile and were labeled
with both uridine and leucine. Also evident was
leucine-labeled procapsid and uridine-labeled
viral ribonucleoprotein. Treatment of the frac-
tions with ribonuclease had no effect on the
provirions or virions (Fig. lb).
After incubation at 37 C for 30 min a number
of effects were evident (Fig. lc). The major
difference was a marked rise in both uridine and
leucine label in the region of the provirion. Most
of the apparent provirion formation observed
occurred during the first 15 min of incubation
(results not shown). Changes in the A260 pattern
were evident; some of these we cannot interpret
but the increased A260 in the provirion region is
evident. Whether or not this increased A260 is
due entirely to provirion or is due partly to a
cosedimenting structure is unclear. Another
effect of incubation at 37 C was an increase in
leucine radioactivity in the procapsid region,
confirming previous results of Phillips and co-
workers (2, 3). The 37 C incubation also in-
creased the uridine radioactivity in structures
sedimenting slower than 100S-these are pre-
sumably breakdown products of the polyribo-
somes and replication complex.
In order to determine if the increased radioac-
tivity in the provirion (125S) region of the
sucrose gradient after incubation was actually
due to provirion formation, the properties of the
material in that region were studied. When the
fractions of the sucrose gradient were treated
with ribonuclease, the uridine label in the 125S
region was not digested (Fig. ld). Ribonuclease-
resistance is a property of the provirion (1).
Analysis of the RNA and protein of the in vitro
product revealed only 35S RNA and procapsid
proteins (not shown) which are the known
components of the provirion. Treatment of the
125S particle with EDTA disrupted it and
generated protein sedimenting at the rate of
procapsid (not shown) which is the behavior
previously found for the provirion (1). There-
fore, by all criteria, the 125S material which
formed after incubation was indistinguishable
from the provirion.
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FIG. 1. Formation of provirion in cell-free extracts. At 3 h after infection with poliovirus, type 1, in the
presence of 5 pg of actinomycin D per ml, 1.6 x 108 HeLa cells were labeled with 3H-leucine (20 ACi/ml) for 30
min and "4C-uridine (0.5 yCi/ml) for the last 15 min and at 3 h 30 min a cell extract in 2 ml of RSB (0.01 M
NaCI, 0.10015M MgCI2, 0.01 M Tris, pH 7.4) was made as described previously (1). One milliliter of the sample
was brought to 1% sodium deoxycholate and 1% Brij-58 and it was kept at 0 C; the other half of the sample was
placed at 37 C and 30 min later was made 1% sodium deoxycholate-1% Brij-58. The samples were layered on 15
to 30% sucrose-RSB gradients and centrifuged at 95,000 x g for 4 h at 4 C. Absorbance was monitored at 260 nm
and fractions of 1 ml were collected. Half of the volume of each fraction was precipitated with I volume of 25%
trichloroacetic acid and radioactivity was measured; the other 0.5 ml of each fraction was made 0.3 M NaCI,
0.03 M Na citrate, and exposed to pancreatic ribonuclease A (10 pg/ml) for 5 min at 37 C before precipitation.
a, Unincubated sample; b, unincubated sample treated with ribonuclease; c, incubated sample; d, incubated
sample treated with ribonuclease. Abbreviations: V, virion; PV, provirion; PC, procapsid.
The above results indicate that there is for-
mation of provirion in a cell-free extract of
poliovirus-infected cells incubated at 37 C. Nei-
ther synthesis of viral RNA nor of viral protein
has been detected under the conditions of
incubation of the extracts which have been used
in the present work. Since provirion consists of
virus-specific proteins and RNA, these mac-
romolecules must therefore be present in some
functional precursor pool in the infected cell
and they must be able to aggregate into the
provirion particle after the disruption of cellular
integrity. The nature of the precursor pool is
under study. Preliminary; experiments indicate
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that 2 mM guanidine hydrochloride does not
block in vitro provirion formation.
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